David Binion, MD
University of Pittsburgh
Pittsburgh, PA

Professor of Medicine
Co-Director, Inflammatory Bowel Disease Center
Director, Nutrition Support Service

Dr. Binion is an internationally recognized expert on Inflammatory Bowel Disease basic science, translational and clinical investigation. His research has been funded by the National Institutes of Health and the Crohn’s and Colitis Foundation of America. His investigation has centered on the cellular and molecular mechanisms of human IBD, with a specific focus on the microvascular biology of chronic intestinal inflammation. His clinical work has centered on developing novel therapies and algorithms for treatment of patients with severe and refractory IBD.

University of Pittsburgh
Division Research Overview and Philosophy

The Division of Gastroenterology, Hepatology and Nutrition is based within a research university and has the fundamental purpose of discovering and teaching new knowledge about digestive diseases. The Faculty and staff of the Division continually evaluate the critical needs of patients with digestive diseases and utilize all available resources to support the highest qualified physicians to determine the exact medical problem faced by each patient, and to link them with outstanding scientists who are able to solve specific problems that currently have no answers.

The Division is not a freestanding organization. The strengths of the Division include partnership with the UPMC system, which provides state-of-the-art facilities, equipment and ancillary support. The Division's clinical faculty collaborate with world-class faculty from other divisions and departments who provide unique and complementary perspectives and abilities. The Division's research faculty are fully integrated into the enormous research enterprise of the University of Pittsburgh. However, the primary goal and strength of the Division is uniting the physicians and scientists to purposefully and systematically tackle the toughest problems in complex digestive diseases.

There are a number of important academic GI divisions throughout the United States, each with different strengths and focuses. The Division of Gastroenterology, Hepatology and Nutrition at the University of Pittsburgh has chosen to concentrate of complex chronic disorders that involve gene-environment interactions, inflammation, neural maladaptation, and cancer development. Examples of these disorders include liver inflammation and cirrhosis, acute and chronic pancreatitis and inflammatory bowel diseases. The integrated programs systematically study the causes and complications of organ dysfunction including inflammation, fibrosis, organ dysfunction, pain, maldigestion and inadequate nutrient absorption, and cancer predisposition, development, prevention and early treatment.

Clinical trials are organized through one of the seven Center of Excellence. The basic science efforts are organized into Genetics, Immunology, Neurosciences, and Molecular Epidemiology. The major laboratories within the Division are listed below. In addition, the Division has joined the Departments of Anesthesiology and Neurobiology to form a new Comprehensive Pain Center, and helped recruit Professor Gerald Gebhart PhD as the first Center Director. A major focus will be the Visceral Pain and Inflammation Program - VIP Program - to work on digestive disorders characterized by pain.

Content available soon!

Content available soon!

    Webcasts

    New and Emerging: Anticytokine Therapies in IBD

    Didactic Lecture

    view details >

    Impact of IBD on Healthcare Systems

    Gary Lichtenstein, MD ; David Rubin, MD ; Bruce Sands, MD ; Brennan Spiegel, MD ; Douglas Wolf, MD

    Didactic Lecture

    view details >

    eMonograph

    GI Alliance Payer Summit

    view details >

    Clinical and Managed Care Perspectives in Inflammatory Bowel Disease: Closing the Gap

    view details >

    Addressing Health Outcomes and Rising Costs in the Management of Inflammatory Bowel Disease

    view details >

    The Guide to Guidelines in IBD: Interpretation and Appropriate Use in Clinical Practice

    view details >

    INFORM UC: An Update on Contemporary Management of UC

    view details >

    Breaking The Barriers: Improving Access to Biologic Therapies in IBD

    view details >

    IBD Management: State of the Art in 2018

    view details >

    Improving IBD Care A Personalized Approach to Management

    view details >

    Expert Perspectives in the Management of Inflammatory Bowel Disease (IBD): A Review of Recent Advances

    view details >

    Advances in IBD

    view details >

    Optimizing the Management of Inflammatory Bowel Disease

    view details >

    Webcasts

    New and Emerging: Anticytokine Therapies in IBD

    Didactic Lecture

    view details >

    Impact of IBD on Healthcare Systems

    Gary Lichtenstein, MD ; David Rubin, MD ; Bruce Sands, MD ; Brennan Spiegel, MD ; Douglas Wolf, MD

    Didactic Lecture

    view details >

    Dinner Meetings

    Content available soon

    Audiocasts

    Content available soon!

    Content available soon!

    © Copyright 2013-2025 GI Health Foundation. All rights reserved.
    This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.